EUVIMEDEUVIMED entdecken
Crossref

Molecular docking and prediction of ADME/Drug-Likeness properties of potentially active neuroprotective compounds in mixed ethanolic extracts of Rosmarinus officinalis and Curcuma longa

Felicia Nmeazi Okwakpam, Iheanyichukwu Wopara, Precious Ojo Uahomo, Miebaka Jamabo

Journal of Bioscience and Biotechnology Discovery · 30.04.2025 · 10 (1) · 8-20

DOI: 10.31248/jbbd2025.227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bioscience and Biotechnology Discovery, online erschienen am 30.04.2025. Verfasst von Felicia Nmeazi Okwakpam und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) and other neurodegenerative disorders are characterized by cholinergic dysfunction, making acetylcholinesterase (AChE) inhibition a therapeutic target. This study investigates the neuroprotective potential of phytoconstituents from Rosmarinus officinalis and Curcuma longa, aiming to identify and evaluate bioactive compounds as potential AChE inhibitors. Ethanolic extracts of R. officinalis and C. longa were analyzed using GC-MS and UHPLC-ESI-Q-TOF-MS/MS to identify key phytoconstituents. Molecular docking simulations were performed using PyRx to assess binding affinities between AChE (PDB ID: 1AMN) and the compounds, including Cycloeicosane, Octacosane, and cis-Vaccenic acid, alongside the standard substrate choline. Drug-likeness, physicochemical properties, lipophilicity, and solubility profiles were predicted using SwissADME, Open Babel for energy minimization, and Silicos-IT for specific solubility and lipophilicity predictions. The docking scores ranged from -6.3 to -7.8 kcal/mol for the identified compounds, significantly outperforming choline (-4.8 kcal/mol). Cycloeicosane exhibited the strongest binding (-7.8 kcal/mol), stabilized by hydrogen, π-sulfur, and multiple alkyl interactions. Physicochemical analysis revealed the hydrophobic nature of most compounds, while cis-Vaccenic acid demonstrated moderate solubility and balanced lipophilicity, enhancing its bioavailability potential. The findings indicate that compounds such as Cycloeicosane and cis-Vaccenic acid are promising AChE inhibitors, offering potential as therapeutic agents for AD. This suggests that the identified phytocompounds could be developed as a novel neuroprotective medication. While computational results are promising, in vitro validation, pharmacokinetic studies, and toxicity assessments are required to confirm their therapeutic efficacy and safety for clinical applications.

Zitieren

APA

Okwakpam, F. N., Wopara, I., Uahomo, P. O., & Jamabo, M. (2025). Molecular docking and prediction of ADME/Drug-Likeness properties of potentially active neuroprotective compounds in mixed ethanolic extracts of Rosmarinus officinalis and Curcuma longa. Journal of Bioscience and Biotechnology Discovery, 10(1), 8-20. https://doi.org/10.31248/jbbd2025.227

Vancouver

Okwakpam FN, Wopara I, Uahomo PO, Jamabo M. Molecular docking and prediction of ADME/Drug-Likeness properties of potentially active neuroprotective compounds in mixed ethanolic extracts of Rosmarinus officinalis and Curcuma longa. Journal of Bioscience and Biotechnology Discovery. 2025;10(1):8-20. doi:10.31248/jbbd2025.227

BibTeX
@article{Okwakpam2025,
  author = {Okwakpam, Felicia Nmeazi and Wopara, Iheanyichukwu and Uahomo, Precious Ojo and Jamabo, Miebaka},
  title = {Molecular docking and prediction of ADME/Drug-Likeness properties of potentially active neuroprotective compounds in mixed ethanolic extracts of Rosmarinus officinalis and Curcuma longa},
  journal = {Journal of Bioscience and Biotechnology Discovery},
  year = {2025},
  volume = {10},
  number = {1},
  pages = {8--20},
  doi = {10.31248/jbbd2025.227}
}
Kostenlos starten →